Stocklytics Platform
Asset logo for symbol FNA
Paragon 28
FNA59
$13.03arrow_drop_up0.07%$0.00
Asset logo for symbol FNA
FNA59

$13.03

arrow_drop_up0.07%
Key Stats
Open$13.02
Prev. Close$13.02
EPS-0.67
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range13.00
13.03
52 Week Range4.66
14.79
Ratios
EPS-0.67
Fundamentals
Payout Ratio-
Industry average yield2.92%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

FNA-
US Healthcare Sector-
US Market-
warning

FNA / Market

FNA lose to the US Market which returned 2.09% over the last twenty four hours.
warning

FNA / Healthcare Sector

FNA lose to the US Healthcare sector which returned 3.60% over the last twenty four hours.

Paragon 28 (FNA) Statistics

Paragon 28, Inc., FNA is a medical device company that specializes in the design and manufacture of innovative products for the foot and ankle market. With a focus on delivering advanced solutions for surgical procedures, Paragon 28 is committed to improving patient outcomes and enhancing the surgeon experience. The company has a strong track record of developing innovative products that address the unique challenges of foot and ankle surgery.
As a leader in the industry, Paragon 28 has achieved impressive stock statistics and valuation metrics. The stock has performed exceptionally well compared to its sector, outperforming the market and delivering strong returns for investors. The company's revenue per share is also impressive, indicating a healthy financial performance.
add Paragon 28 to watchlist

Keep an eye on Paragon 28

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Paragon 28 (FNA) stock's performance compared to its sector and the market over the past year?

Over the past year, Paragon 28 (FNA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 20.50%, Paragon 28 has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 34.29%, it has fallen short of the market average. This comparison highlights Paragon 28's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Paragon 28 (FNA) stock?

The PE ratio for Paragon 28 (FNA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Paragon 28 (FNA) stock?

The Earnings Per Share (EPS) for Paragon 28 (FNA), calculated on a diluted basis, is -$0.67. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Paragon 28 (FNA) stock?

The operating margin for Paragon 28 (FNA) is -13.56%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Paragon 28 (FNA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Paragon 28 (FNA) is -$21.47M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Paragon 28 (FNA) have?

Paragon 28 (FNA) has a total debt of $111.61M. The net debt, which accounts for cash and cash equivalents against the total debt, is $71.47M.

Take Your Investments to a Whole New Level